Free Trial

IceCure Medical (ICCM) Competitors

IceCure Medical logo
$1.02 -0.01 (-0.97%)
Closing price 04:00 PM Eastern
Extended Trading
$1.03 +0.01 (+1.47%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ICCM vs. NVRO, DRTS, SKIN, CATX, BWAY, LAKE, ELMD, CVRX, RCEL, and SGHT

Should you be buying IceCure Medical stock or one of its competitors? The main competitors of IceCure Medical include Nevro (NVRO), Alpha Tau Medical (DRTS), Beauty Health (SKIN), Perspective Therapeutics (CATX), BrainsWay (BWAY), Lakeland Industries (LAKE), Electromed (ELMD), CVRx (CVRX), AVITA Medical (RCEL), and Sight Sciences (SGHT). These companies are all part of the "medical equipment" industry.

IceCure Medical vs.

IceCure Medical (NASDAQ:ICCM) and Nevro (NYSE:NVRO) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership, risk and community ranking.

Nevro received 478 more outperform votes than IceCure Medical when rated by MarketBeat users. However, 96.30% of users gave IceCure Medical an outperform vote while only 62.07% of users gave Nevro an outperform vote.

CompanyUnderperformOutperform
IceCure MedicalOutperform Votes
26
96.30%
Underperform Votes
1
3.70%
NevroOutperform Votes
504
62.07%
Underperform Votes
308
37.93%

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 95.5% of Nevro shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 3.2% of Nevro shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

IceCure Medical presently has a consensus target price of $2.50, indicating a potential upside of 145.10%. Nevro has a consensus target price of $5.36, indicating a potential downside of 8.29%. Given IceCure Medical's stronger consensus rating and higher possible upside, equities analysts plainly believe IceCure Medical is more favorable than Nevro.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.50
Nevro
2 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.92

IceCure Medical has higher earnings, but lower revenue than Nevro. IceCure Medical is trading at a lower price-to-earnings ratio than Nevro, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IceCure Medical$3.29M17.20-$14.65M-$0.30-3.40
Nevro$408.52M0.55-$92.21M-$3.05-1.92

IceCure Medical has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Comparatively, Nevro has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500.

Nevro has a net margin of -16.54% compared to IceCure Medical's net margin of -376.85%. Nevro's return on equity of -23.52% beat IceCure Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
IceCure Medical-376.85% -124.44% -87.70%
Nevro -16.54%-23.52%-10.83%

In the previous week, IceCure Medical had 2 more articles in the media than Nevro. MarketBeat recorded 3 mentions for IceCure Medical and 1 mentions for Nevro. IceCure Medical's average media sentiment score of 0.42 beat Nevro's score of 0.00 indicating that IceCure Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IceCure Medical
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Nevro
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

IceCure Medical and Nevro tied by winning 9 of the 18 factors compared between the two stocks.

Get IceCure Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICCM vs. The Competition

MetricIceCure MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$56.61M$4.43B$5.33B$8.39B
Dividend YieldN/A43.63%5.21%4.11%
P/E Ratio-3.5229.0826.7119.71
Price / Sales17.2066.76386.13120.55
Price / CashN/A51.0838.2534.62
Price / Book3.786.196.774.50
Net Income-$14.65M$67.60M$3.23B$248.22M
7 Day Performance-0.97%-0.63%1.80%0.56%
1 Month Performance-10.53%17.91%11.10%13.17%
1 Year Performance-3.77%21.16%17.11%7.30%

IceCure Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICCM
IceCure Medical
2.0849 of 5 stars
$1.02
-1.0%
$2.50
+145.1%
-5.5%$56.61M$3.29M-3.5260News Coverage
Positive News
Upcoming Earnings
Gap Up
NVRO
Nevro
0.2074 of 5 stars
$5.85
+0.1%
$5.36
-8.3%
-41.3%$224.32M$408.52M-3.091,090
DRTS
Alpha Tau Medical
1.9797 of 5 stars
$3.10
+11.1%
$8.00
+158.1%
+14.3%$218.18MN/A-7.2180Earnings Report
High Trading Volume
SKIN
Beauty Health
0.3791 of 5 stars
$1.64
-5.7%
$1.42
-13.6%
-41.1%$205.40M$322.47M-3.901,030Positive News
CATX
Perspective Therapeutics
3.4274 of 5 stars
$2.73
+3.8%
$12.50
+357.9%
-84.4%$202.64M$1.43M0.0070News Coverage
Analyst Revision
BWAY
BrainsWay
3.7197 of 5 stars
$10.65
+7.5%
$14.25
+33.8%
+91.5%$200.99M$43.46M106.51120
LAKE
Lakeland Industries
4.726 of 5 stars
$19.44
+1.9%
$27.00
+38.9%
+6.5%$184.89M$167.21M-216.001,800News Coverage
Positive News
Gap Up
ELMD
Electromed
1.2123 of 5 stars
$21.99
+2.0%
$38.00
+72.8%
+24.4%$184.41M$59.63M29.32160Positive News
CVRX
CVRx
2.844 of 5 stars
$6.85
+8.0%
$14.50
+111.7%
-24.7%$178.60M$52.87M-2.55160Gap Down
RCEL
AVITA Medical
1.3951 of 5 stars
$6.74
+4.3%
$17.25
+155.9%
-19.9%$178.17M$71.66M-2.82130
SGHT
Sight Sciences
3.4047 of 5 stars
$3.27
-7.9%
$3.92
+19.8%
-40.7%$169.05M$78.11M-3.21210Analyst Forecast
Gap Up

Related Companies and Tools


This page (NASDAQ:ICCM) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners